The use of benzisoselenazolone compounds against ischemic...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/41 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2493865

The present invention disclosed the use of benzisoselenazolone compounds, particularly the compounds represented by the general formula (1) as the medicament useful against ischemic myocardial damage. Said compounds are highly active and specific with low toxicity, characterized by selectively inhibiting the exchange of Na/Ca, dilating the blood vessel and reducing the amount of oxygen consumed by myocardial tissue.

L'invention concerne l'utilisation de composés benzisosélénazolones, notamment des composés représentés par la formule générale (I) en tant que médicament utile contre les lésions myocardiques ischémiques. Lesdits composés sont hautement actifs et spécifiques avec une faible toxicité, et se caractérisent en ce qu'ils inhibent sélectivement l'échange de Na/Ca, qu'ils dilatent les vaisseaux sanguins et qu'ils réduisent le taux d'oxygène consommé par le tissu myocardique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

The use of benzisoselenazolone compounds against ischemic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The use of benzisoselenazolone compounds against ischemic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of benzisoselenazolone compounds against ischemic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1910159

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.